Alfin Pharmaceutical Private Limited
About Alfin Pharmaceutical Private Limited
Data last updated:
Alfin Pharmaceutical Private Limited is a private limited company based in Patna, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24232BR2013PTC021563. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Nutan Singh and Rajwardhan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Patna, Bihar.
As per the financials filed for FY 2024, the company reported a revenue of ₹38.91 Lakh, a decline of 25% compared to the previous year. For the same year it recorded a net loss of ₹1.45 Lakh (net margin -3.7%) and EBITDA of -₹1.44 Lakh (EBITDA margin -3.7%). Revenue has grown at a compounded annual rate (CAGR) of 49% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Alfin Pharmaceutical Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No – 305 Wazir Apartment Behind Alpana Market New Patliputra Col, Ony, Patna, Bihar, India – 800013
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Alfin Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Alfin Pharmaceutical Private Limited
FY 2025 filings availableAlfin Pharmaceutical Private Limited reported revenue of ₹38.91 Lakh (down 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 25% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 49%. EBITDA fell 378% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.45 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.7% | ||||
| Net Profit Margin | -3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alfin Pharmaceutical Private Limited, buy the company report.
Board of directors of Alfin Pharmaceutical Private Limited
Alfin Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nutan Singh Also directs: NN Ventures Private Limited, Koshi Kalyan Foundation | Director | 29 Nov 2013 | 12 Years 11 Months | Current |
| Rajwardhan | Additional Director | 25 May 2022 | 4 Years 5 Months | Current |
Shareholding
The shareholding of Alfin Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Alfin Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alfin Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alfin Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alfin Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Alfin Pharmaceutical Private Limited, buy the company report.
Recent activity
Alfin Pharmaceutical Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Niraj Kumar Singh ceased to be Director on 25 May 2022.
Frequently asked questions
Alfin Pharmaceutical is an active private limited company based in Patna, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 November 2013 (13+ years old) and is registered under CIN U24232BR2013PTC021563.
Alfin Pharmaceutical has 2 current directors:
- Nutan Singh - Director
- Rajwardhan - Additional Director
The latest financial statements of Alfin Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Alfin Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Alfin Pharmaceutical is U24232BR2013PTC021563. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alfin Pharmaceutical was incorporated on 29 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Patna.
Niraj Kumar Singh ceased to be Director on 25 May 2022. Rajwardhan was appointed as Additional Director on 25 May 2022. Nutan Singh was appointed as Director on 29 Nov 2013.
The registered office of Alfin Pharmaceutical is at Flat No – 305 Wazir Apartment Behind Alpana Market New Patliputra Col, Ony, Patna, Bihar, India – 800013.
Alfin Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Alfin Pharmaceutical is active non-compliant as of 04 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
